These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18458214)

  • 1. Atrophy accelerates with conversion from mild cognitive impairment to Alzheimer disease.
    Mueller SG; Dickerson BC
    Neurology; 2008 May; 70(19 Pt 2):1728-9. PubMed ID: 18458214
    [No Abstract]   [Full Text] [Related]  

  • 2. Conversion from subtypes of mild cognitive impairment to Alzheimer dementia.
    Hussain H
    Neurology; 2007 Jul; 69(4):409. PubMed ID: 17646640
    [No Abstract]   [Full Text] [Related]  

  • 3. Is amnestic mild cognitive impairment always AD?
    Jagust W
    Neurology; 2008 Feb; 70(7):502-3. PubMed ID: 18268243
    [No Abstract]   [Full Text] [Related]  

  • 4. Thin skin: the cortical signature of prodromal AD?
    Rottenberg DA
    Neurology; 2009 Mar; 72(12):1038-9. PubMed ID: 19109535
    [No Abstract]   [Full Text] [Related]  

  • 5. Normative estimates of cross-sectional and longitudinal brain volume decline in aging and AD.
    Fotenos AF; Snyder AZ; Girton LE; Morris JC; Buckner RL
    Neurology; 2005 Mar; 64(6):1032-9. PubMed ID: 15781822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hippocampal atrophy and EEG markers in subjects with mild cognitive impairment.
    Moretti DV; Miniussi C; Frisoni GB; Geroldi C; Zanetti O; Binetti G; Rossini PM
    Clin Neurophysiol; 2007 Dec; 118(12):2716-29. PubMed ID: 17977786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual rating system for assessing magnetic resonance images: a tool in the diagnosis of mild cognitive impairment and Alzheimer disease.
    Urs R; Potter E; Barker W; Appel J; Loewenstein DA; Zhao W; Duara R
    J Comput Assist Tomogr; 2009; 33(1):73-8. PubMed ID: 19188789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylated tau predicts rate of cognitive decline in MCI subjects: a comparative CSF study.
    Buerger K; Ewers M; Andreasen N; Zinkowski R; Ishiguro K; Vanmechelen E; Teipel SJ; Graz C; Blennow K; Hampel H
    Neurology; 2005 Nov; 65(9):1502-3. PubMed ID: 16275849
    [No Abstract]   [Full Text] [Related]  

  • 9. Maximizing the Alzheimer's Disease Neuroimaging Initiative II.
    Carrillo MC; Sanders CA; Katz RG
    Alzheimers Dement; 2009 May; 5(3):271-5. PubMed ID: 19362888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular risk factors and cognitive decline among elderly male twins.
    Gotkine M
    Neurology; 2007 May; 68(21):1871; author reply 1871. PubMed ID: 17515556
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuroanatomic basis of amnestic MCI differs in patients with and without Parkinson disease.
    Lee JE; Park HJ; Song SK; Sohn YH; Lee JD; Lee PH
    Neurology; 2010 Nov; 75(22):2009-16. PubMed ID: 21115956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of prodromal Alzheimer's disease.
    Mortimer JA; Petersen RC
    Ann Neurol; 2008 Nov; 64(5):479-80. PubMed ID: 19067352
    [No Abstract]   [Full Text] [Related]  

  • 13. Mild cognitive impairment in the elderly.
    Brandt J
    Am Fam Physician; 2001 Feb; 63(4):620, 622, 625-6. PubMed ID: 11237076
    [No Abstract]   [Full Text] [Related]  

  • 14. The importance of Alzheimer disease assessment scale-cognitive part in predicting progress for amnestic mild cognitive impairment to Alzheimer disease.
    Rozzini L; Vicini Chilovi B; Bertoletti E; Conti M; Delrio I; Trabucchi M; Padovani A
    J Geriatr Psychiatry Neurol; 2008 Dec; 21(4):261-7. PubMed ID: 19017783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated hippocampal atrophy rates in stable and progressive amnestic mild cognitive impairment.
    Wang PN; Liu HC; Lirng JF; Lin KN; Wu ZA
    Psychiatry Res; 2009 Mar; 171(3):221-31. PubMed ID: 19217759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive aging research at Mayo Clinic.
    Petersen LE; Hammon J; McCormick J; Petersen RC
    Minn Med; 2002 Sep; 85(9):29-31. PubMed ID: 12387118
    [No Abstract]   [Full Text] [Related]  

  • 17. MRI brain volumetry in Rasmussen encephalitis: the fate of affected and "unaffected" hemispheres.
    Larionov S; König R; Urbach H; Sassen R; Elger CE; Bien CG
    Neurology; 2005 Mar; 64(5):885-7. PubMed ID: 15753429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative EEG in progressing vs stable mild cognitive impairment (MCI): results of a 1-year follow-up study.
    Luckhaus C; Grass-Kapanke B; Blaeser I; Ihl R; Supprian T; Winterer G; Zielasek J; Brinkmeyer J
    Int J Geriatr Psychiatry; 2008 Nov; 23(11):1148-55. PubMed ID: 18537220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New developments in the treatment of Alzheimer's disease.
    J Clin Psychiatry; 2009 Feb; 70(2):281-90. PubMed ID: 19265644
    [No Abstract]   [Full Text] [Related]  

  • 20. [MCI-plus: mild cognitive impairment with rapid progression. Part II: Biomarkers and research methods].
    Förstl H; Werheid K; Ulm K; Schönknecht P; Schmidt R; Pantel J; Hörr R; Gutzmann H; Gertz HJ; Frölich L; Bickel H
    Dtsch Med Wochenschr; 2009 Jan; 134(3):88-91. PubMed ID: 19142839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.